联系客服

301212 深市 联盛化学


首页 公告 联盛化学:浙江联盛化学股份有限公司2023年财务决算报告

联盛化学:浙江联盛化学股份有限公司2023年财务决算报告

公告日期:2024-04-26

联盛化学:浙江联盛化学股份有限公司2023年财务决算报告 PDF查看PDF原文

            浙江联盛化学股份有限公司

                2023 年财务决算报告

一、2023 年度公司整体经营情况

  2023 年度,浙江联盛化学股份有限公司(以下简称“公司”)全年实现营业总收入为 662,015,730.44 元,同比下降 36.41%;归属于上市公司股东的净利润为 71,112,773.72 元,同比下降 61.13%。
二、2023 年度公司财务报告审计情况

  公司 2023 年度财务报表已经容诚会计师事务所(特殊普通合伙)审计,并出具了容诚审字[2024]100Z0830 号无保留意见的审计报告。
三、2023 年度主要财务数据和指标

                                                                    单位:元

          项目                2023 年        2022 年      本年比上年增减

 营业收入                    662,015,730.44 1,041,133,695.75        -36.41%

 归属于上市公司股东的净利润    71,112,773.72  182,965,402.93        -61.13%

 归属于上市公司股东的扣除非    67,011,804.83  181,183,427.77        -63.01%
 经常性损益的净利润

 经营活动产生的现金流量净额    193,755,940.16    -5,026,134.96        3,954.97%

 基本每股收益(元/股)                  0.66            1.85          -64.32%

 稀释每股收益(元/股)                  0.66            1.85          -64.32%

 加权平均净资产收益率                5.37%        18.47%          -13.10%

                              2023 年末          2022 年未  本年比上年增减

 资产总额                    1,683,513,672.39 1,648,907,339.15          2.10%

 归属于上市公司股东的净资产  1,343,624,141.08 1,313,229,934.85          2.31%

四、2023 年公司的资产、负债状况

                                                                    单位:元

          项目                2023 年        2022 年    本年比上年增减

 货币资金                      570,593,746.68  716,585,385.19        -20.37%

 交易性金融资产                113,213,037.42  43,223,038.15        161.93%

 应收票据                      59,794,636.54  132,523,576.44        -54.88%

 应收账款                      56,422,428.53  130,926,297.97        -56.91%

 应收款项融资                  39,955,192.24          0.00            100%

 预付款项                        3,457,048.74  11,280,917.36          -69.35%

 其他应收款                      2,400,034.72    5,968,570.67          -59.79%

 存货                          115,782,015.47  107,264,309.16          7.94%

 其他流动资产                  16,768,345.77    6,116,193.40        174.16%

 在建工程                      296,462,705.95  116,784,077.37        153.86%

 其他非流动资产                74,908,146.99  38,833,065.80          92.90%

 短期借款                        3,981,469.33    6,006,715.98          -33.72%

 应付票据                      134,070,745.54  183,358,648.43        -26.88%

 应付账款                      88,205,942.16  68,267,240.86          29.21%

 合同负债                        733,633.35    5,775,067.91          -87.30%

 其他应付款                      253,528.08    144,033.81          76.02%

 递延收益                      21,547,092.72  12,928,556.72          66.66%

 其他非流动负债                        0.00    2,295,659.39          -100%

    上表中变动幅度超过 30%的主要项目说明如下:

    (1)交易性金融资产较上年末增加 161.93%,主要系银行理财产品投资增
加所致;

    (2)应收票据较上年减少 54.88%,主要系营业收入减少,货款采用银行
承兑汇票结算减少,6+9 银行签收应收票据列报应收款项融资所致;

    (3)应收账款较上年末减少 56.91%,主要系营业收入规模减小所致;

    (4)应收款项融资较上年末增加 100%,主要系 6+9 银行签收应收票据列
报应收款项融资所致;

    (5)预付款项较上年末减少 69.35%,主要系预付材料款减少所致;

    (6)其他应收款较上年末减少 59.79%,主要系应收出口退税减少所致;
    (7)其他流动资产较上年末增加 174.16%,主要系期末增值税留抵税额较
上年增加所致;

    (8)在建工程较上年末增加 153.86%,主要系本年度募投项目和年产

8,000 吨草酸二乙酯(DEO)联产等项目持续投入所致;

    (9)其他非流动资产较上年末增加 92.90%,主要系长期资产采购预付款
增加所致;


    (11)合同负债较上年末减少 87.30%,主要系持有待售资产处置完成;
    (12)其他应付款较上年末增加 76.02%,主要系职工个人社保代垫款增加
所致;

    (13)递延收益较上年末增加 66.66%,主要系收到与资产相关的政府补助
所致;

    (14)其他非流动负债较上年未减少 100%,主要系 CTEG 工业化技术合
作研发经费已清算结清所致。
五、2023 年公司的经营状况

                                                                    单位:元

          项目                2023 年        2022 年      本年比上年增减

 营业收入                    662,015,730.44 1,041,133,695.75          -36.41%

 营业成本                    535,696,699.55  788,855,249.29          -32.09%

 税金及附加                    3,968,974.41    4,514,683.07          -12.09%

 销售费用                      9,264,323.96    10,888,230.25          -14.91%

 管理费用                      32,335,289.33    30,093,634.04          7.45%

 研发费用                      25,566,012.19    32,940,383.29          -22.39%

 财务费用                      -22,370,380.28  -45,511,483.08          50.85%

 其他收益                      7,317,873.50    5,746,659.54          27.34%

 投资收益                        585,854.73    -2,678,277.38        121.87%

 公允价值变动收益                280,472.98    1,132,076.03          -75.22%

 信用减值损失(损失以“-”      3,863,295.56      -44,633.58        8,755.58%
 号填列)

 资产减值损失(损失以“-”      -6,338,763.92    -2,386,190.76        -165.64%
 号填列)

 资产处置收益(损失以“-”      -1,051,245.29      37,926.41      -2,871.80%
 号填列)

 营业利润                      82,212,298.84  221,160,559.15          -62.83%

 营业外收入                      857,680.59        2,822.78      30,284.25%

 营业外支出                      856,675.46    2,419,579.67          -64.59%

 利润总额                      82,213,303.97  218,743,802.26          -62.42%

 所得税费用                    10,456,875.07    27,579,765.79          -62.08%

 净利润                        71,756,428.90  191,164,036.47          -
[点击查看PDF原文]